PTPN11 and liver cancer: We simulated diabetes‐related liver cancer cell models by inducing IR to HCC cells and discovered that the expression of SHP2 was increased in cell models, suggesting that SHP2 could promote the occurrence of IR and thus trigger the progression of diabetes‐related liver cancer.